Cubist Systematic Strategies, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Cubist Systematic Strategies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.58 - $12.25 $111,971 - $180,957	14,772 New	14,772 $180,000
Q3 2022 Nov 14, 2022	SELL	$9.85 - $16.83 $383,036 - $654,468	-38,887 Reduced 76.98%	11,627 $169,000
Q2 2022 Aug 15, 2022	BUY	$8.16 - $15.1 $412,194 - $762,761	50,514 New	50,514 $497,000
Q1 2022 May 16, 2022	SELL	$11.2 - $16.97 $190,198 - $288,184	-16,982 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$12.36 - $18.28 $209,897 - $310,430	16,982 New	16,982 $225,000
Q4 2019 Feb 14, 2020	SELL	$10.31 - $17.81 $8,062 - $13,927	-782 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$11.6 - $21.67 $13,015 - $24,313	-1,122 Reduced 58.93%	782 $9,000
Q2 2019 Aug 14, 2019	BUY	$18.44 - $30.89 $35,109 - $58,814	1,904 New	1,904 $42,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.